Tests of trait - Haplotype association when linkage phase is ambiguous, appropriate for matched case-control and cohort studies with competing risks

Statistics in Medicine

Volumn 24, Issue 15, 2005, Pages 2299-2316

  Flanders, William D ^a   Khoury, M J ^b   Yang, Q H ^b   Austin, H ^a  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Association; Case control; Competing risks; Conditional logistic regression; Disease; Epidemiology; Genetics; Haplotypes; Linkage; Logistic model; Proportional hazards model; Score tests; Single nucleotide polymorphisms; Statistics; Survival

Indexed keywords

THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ADULT; ANALYTICAL ERROR; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRAIT; GENOTYPE; HAPLOTYPE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MORTALITY; RISK ASSESSMENT; SCORING SYSTEM; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; CARBOXYPEPTIDASE U; CASE-CONTROL STUDIES; COHORT STUDIES; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); LOGISTIC MODELS; MIDDLE AGED; POLYMORPHISM, GENETIC; PULMONARY EMBOLISM; QUANTITATIVE TRAIT LOCI; VENOUS THROMBOSIS;

EID: 23244447183     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2156     Document Type: Article

References (34)

1. Little J, Khoury MJ, Bradley L, Clyne M, Gwinn M, Lin B, Lindegren ML, Yoon P. The human genome project is complete. How do we develop a handle for the pump? American Journal of Epidemiology 2003; 157(8):667-673.
2. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics 2002; 70:425-434.
3. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough DP, Nguyen BT, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA, Fodor SP, Cox DR. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001; 294(5547):1719-1723.
4. Zhang K, Calabrese P, Nordborg M, Sun F. Haplotype block structure and its applications to association studies: power and study designs. American Journal of Human Genetics 2002; 71(6):1386-1394.
5. Thomas DC, Morrison JL, Clayton DG. Bayes estimates of haplotype effects. Genetic Epidemiology 2001; 21(Suppl 1):S712-S717.
6. Zaykin DV, Westfall PH, Young MA, Karnoub MA et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Human Heredity 2002; 53:79-91.
7. Li H. A permutation procedure for the haplotype method for identification of disease-predisposing variants. Annals of Human Genetics 2002; 65(Part 2):189-196.
8. Zhao LP, Li SS, Khalid N. A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. American Journal of Human Genetics 2003; 72(5):1231-1250.
9. Cox DR. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
10. Cox DR. Partial likelihood. Biometrika 1975; 62:269-276.
11. Anderson PK, Gill RD. Cox's regression model for counting processes: a large sample study. Annals of Statistics 1982; 10:1100-1120.
12. Hooper WC, Dowling NF, De Staercke C, Miller CH, Whitsett C, Beckman MG, Evatt BL, Austin H. Thrombin activable fibrinolysis inhibitor genetic polymorphisms are associated with pulmonary embolism but not with deep vein thrombosis in Caucasians. No Association Found in African Americans. Manuscript, 2004.
13. Schuit SCE, Oei HHS, Witteman JCM, van Kessel CHG, van Meurs JBJ, Nijhuis RL, van Leeuwen JPTM, de Jong FH, Zillikens MC, Hofman A, Pols HAP, Uitterlinden AGA. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. Journal of the American Medical Association 2004; 291:2969-2977.
14. Shearman AM, Cupples LA, Demissie S et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. Journal of the American Medical Association 2003; 290:2263-2270.
15. US DHHS, CDC, NCHS, OAEHP, CMF 1999-2001, Series 20, No. 2G 2004 on CDC WONDER, On line database, accessed 1 July 2004.
16. Laquemant C, Froguel P, Lobbens S, Izzo P, Dina C, Ruiz J. The adiponectin gene SNB+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetic Medicine 2004; 21: 776-781.
17. Heijmans BT, Westendorp RGJ, Lagaay AM, KnookDL, Kluft C, Slagboom PE. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 2000; 149:91-97.
18. Eriksson P, Deguchi H, Samnegord A, Lundman P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arteriosclerosis Thrombosis and Vascular Biology 2004; 24:551-557.
19. Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L for the AtheroGene Investigators. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Human Molecular Genetics 2004; 13:1341-1351.
20. Han W, Kang D, Lee KM, Kim HJ, Ahn SJ, Kim SW, Chung KW, Lee ES, Noh DY. Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk. Anticancer Research 2003; 23:4703-4707.
21. Rothman KJ, Greenland S. Modern Epidemiology (2nd edn). Lippincott Raven: Philadelphia, PA, 1998.
22. Li H, Thompson E. Semiparametric estimation of major gene and family-specific random effects for age of onset. Biometrics 1997; 53:282-293.
23. Lam KF, Lee YW, Leung TL. Modeling multivariate survival data by a semiparametric random effects proportional odds model. Biometrics 2002; 58:316-323.
24. Maples JJ, Murphy SA, Axinn WG. Two-level proportional hazards models. Biometrics 2002; 58:754-763.
25. Gorfine M, Hsu L, Prentice RL. Nonparametric correction for covariate measurement error in a stratified Cox model. Biostatistics 2004; 5:754-763.
26. Cordell HJ, Clayton DB. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms with a gene using case/control or family data: application to HLA in type1 diabetes. American Journal of Human Genetics 2002; 70:124-141.
27. Flanders WD, Barnhart HX, Kosinski AS. An estimated score method for missing and auxiliary covariates in two stage studies. Journal of Statistical Planning and Inference 2003; 115:145-170.
28. Robins JM, Hsieh F, Newey W. Semiparametric efficient estimation of a conditional density with missing or mismeasured covariates. Journal of the Royal Statistical Society 1995; 57:409-424.
29. Lipsitz SR, Ibrahim JG. Estimating equations with incomplete categorical covariates in the Cox model. Biometrics 1998; 54:1002-1013.
30. Lubin JH. An empirical evaluation of the use of conditional and unconditional likelihoods for case-control data. Biometrika 1981; 68:567-571.
31. Elbaz A, Alperovitch A. Bias in association studies resulting from gene-environment interactions and competing risks. American Journal of Epidemiology 2002; 155:265-273.
32. Tregouet D-A, Tiret L. Cox proportional hazards survival regression in haplotype-based association analysis using the stochastic-EM algorithm. European Journal of Human Genetics 2004; 12:971-974.
33. Lin DY. Haplotype-based association analysis in cohort studies of unrelated individuals. Genetic Epidemiology 2004; 26:255-264.
34. Prentice RL, Pyke R. Logistic disease incidence models and case-control studies. Biometrika 1979; 66: 403-411.